Here’s some of what I saw this year at BiOS and
represents only a small fraction of what was there. I’ll put up a few more links soon. It is fascinating to see all these amazing
developments in biophotonics, biomedical optics, and imaging being made at such
a rapid pace. Thanks to all who
graciously let me point my little camera at them. Please visit their linked websites to learn
more about what is outlined here.
In the order that they appear in the video we
present:
Dipl. - Phys. Uwe Ortmann of PicoQuant returned this year from Berlin with the
latest Fluorescence Lifetime Imaging (FLIM) development to capture motion in
cells at 10 frames per second (FPS).
Aileen Chen of Vista Optronics Inc. came to San
Francisco from China and demonstrated a tiny endoscope (1.5mm outside diameter)
- not much larger than an acupuncture needle.
Justin Harris Ph.D. of NanoHybrids Advanced Imaging Solutions came
from Austin, Texas and explained how gold and light are used for non-invasive
cancer diagnosis and treatment.
Markus Geiser Dr. sc. ETH of IRsweep came from Zurich Switzerland and
demonstrated a new spectrometer with bandwidth of up to 150 cm-1 in the
mid-IR range of 5 µm (2000 cm-1) to 10 µm (1000cm-1).
Ben Alexander of Caliber Imaging and Diagnostics
from Lakeway, Texas demonstrated a new technology for quickly scanning and stitching
together confocal microscope images of biological samples up to 80 x 120 mm.
A world class event showcasing the biological applications of light is once again illuminating The Moscone Center in San Francisco. Part of the huge Photonics West Expo, BiOs is an annual event. Here under one roof we can see many of the latest developments in technologies such as biophotonics,spectroscopy, microscopy, optogenetics, laser surgery, and much more. We shot a video at last year's bios, which will give a basic idea of some of the technology shown there:
This is an excellent program for learning the correct laboratory procedures used in molecular biology labs. Classes start next week so enroll now. http://www.laney.edu/wp/biomanufacturing/
Usually most of the daily news is bad but today we woke up to very good news. rVSV-ZEBOV, a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus has completed phase 1 human trials in Guinea, West Africa. Vaccine efficacy was 100% Fast track this one please (Merck has 300,000 doses ready in case of an outbreak). We are highly impressed by this work and hope it will serve as a model for the future of rapid drug development and deployment in response to emerging epidemics. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32621-6/fulltext